Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes

Molecular Oncology

Volumn 8, Issue 7, 2014, Pages 1306-1325

  Kalamohan, Kalaivani ^a   Periasamy, Jayaprakash ^a   Bhaskar Rao, Divya ^a   Barnabas, Georgina D ^a   Ponnaiyan, Srigayatri ^a   Ganesan, Kumaresan ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

Author keywords

Diffuse subtype; Embryonic stem cells; Gastric cancer; Intestinal subtype; Mesenchymal stem cell differentiation; Mesenchymal stem cells; Notch signaling; Polycomb repression

Indexed keywords

MESSENGER RNA; MYC PROTEIN; NOTCH RECEPTOR; ORGANIC CATION TRANSPORTER 1; TRANSCRIPTION FACTOR E2F; WNT PROTEIN;

ARTICLE; CANCER MORTALITY; CELL LINEAGE; CONTROLLED STUDY; EMBRYONIC STEM CELL; EPIGENETIC REPRESSION; FUNCTIONAL GENOMICS; GASTRIC CANCER CELL LINE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; STOMACH CANCER; TUMOR DIFFERENTIATION; CANCER STEM CELL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; STOMACH; STOMACH TUMOR; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; NEOPLASTIC STEM CELLS; STOMACH; STOMACH NEOPLASMS;

EID: 84908553231     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.04.005     Document Type: Article

References (83)

1. Abdollahi H., Harris L.J., Zhang P., McIlhenny S., Srinivas V., Tulenko T., DiMuzio P.J. The role of hypoxia in stem cell differentiation and therapeutics. J.Surg. Res. 2011, 165:112-117.
2. Aggarwal A., Guo D.L., Hoshida Y., Yuen S.T., Chu K.M., So S., Boussioutas A., Chen X., Bowtell D., Aburatani H., Leung S.Y., Tan P. Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res. 2006, 66:232-241.
3. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
4. Alphonso A., Alahari S.K. Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia 2009, 11:1264-1271.
5. Aranda P., Agirre X., Ballestar E., Andreu E.J., Roman-Gomez J., Prieto I., Martin-Subero J.I., Cigudosa J.C., Siebert R., Esteller M., Prosper F. Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One 2009, 4:e7809.
6. Augsten M., Hagglof C., Pena C., Ostman A. A digest on the role of the tumor microenvironment in gastrointestinal cancers. Cancer Microenviron. 2010, 3:167-176.
7. Barabasi A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004, 5:101-113.
8. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
9. Bhasin M., Yuan L., Keskin D.B., Otu H.H., Libermann T.A., Oettgen P. Bioinformatic identification and characterization of human endothelial cell-restricted genes. BMC Genomics 2010, 11:342.
10. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
11. Calvisi D.F., Conner E.A., Ladu S., Lemmer E.R., Factor V.M., Thorgeirsson S.S. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J.Hepatol. 2005, 42:842-849.
12. Chen X., Leung S.Y., Yuen S.T., Chu K.M., Ji J., Li R., Chan A.S., Law S., Troyanskaya O.G., Wong J., So S., Botstein D., Brown P.O. Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell 2003, 14:3208-3215.
13. Cho J.Y., Lim J.Y., Cheong J.H., Park Y.Y., Yoon S.L., Kim S.M., Kim S.B., Kim H., Hong S.W., Park Y.N., Noh S.H., Park E.S., Chu I.S., Hong W.K., Ajani J.A., Lee J.S. Gene expression signature-based prognostic risk score in gastric cancer. Clin. Cancer Res. 2011, 17:1850-1857.
14. Cho D.Y., Kim Y.A., Przytycka T.M. Chapter 5: network biology approach to complex diseases. Plos Comput. Biol. 2012, 8:e1002820.
15. Culhane A.C., Schwarzl T., Sultana R., Picard K.C., Picard S.C., Lu T.H., Franklin K.R., French S.J., Papenhausen G., Correll M., Quackenbush J. GeneSigDB - a curated database of gene expression signatures. Nucleic Acids Res. 2010, 38:D716-D725.
16. Deng Z.L., Sharff K.A., Tang N., Song W.X., Luo J., Luo X., Chen J., Bennett E., Reid R., Manning D., Xue A., Montag A.G., Luu H.H., Haydon R.C., He T.C. Regulation of osteogenic differentiation during skeletal development. Front Biosci. 2008, 13:2001-2021.
17. Dey P. Epigenetic changes in tumor microenvironment. Indian J. Cancer 2011, 48:507-512.
18. Ding Y.B., Chen G.Y., Xia J.G., Zang X.W., Yang H.Y., Yang L. Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J. Gastroenterol. 2003, 9:1409-1414.
19. Doig T.N., Hume D.A., Theocharidis T., Goodlad J.R., Gregory C.D., Freeman T.C. Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genomics 2013, 14:469.
20. Dreger H., Ludwig A., Weller A., Stangl V., Baumann G., Meiners S., Stangl K. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells. Hypertension 2012, 60:1176-1183.
21. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U S A 1998, 95:14863-14868.
22. Ellinger J., Kahl P., von der Gathen J., Heukamp L.C., Gutgemann I., Walter B., Hofstadter F., Bastian P.J., von Ruecker A., Muller S.C., Rogenhofer S. Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Invest. 2012, 30:92-97.
23. Fiskus W., Pranpat M., Balasis M., Herger B., Rao R., Chinnaiyan A., Atadja P., Bhalla K. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Mol. Cancer Ther. 2006, 5:3096-3104.
24. Forster S., Gretschel S., Jons T., Yashiro M., Kemmner W. THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod. Pathol. 2011, 24:1390-1403.
25. Fredlund E., Staaf J., Rantala J.K., Kallioniemi O., Borg A., Ringner M. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition. Breast Cancer Res. 2012, 14:R113.
26. Ganesan K., Ivanova T., Wu Y., Rajasegaran V., Wu J., Lee M.H., Yu K., Rha S.Y., Chung H.C., Ylstra B., Meijer G., Lian K.O., Grabsch H., Tan P. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res. 2008, 68:4277-4286.
27. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., Martinez P., Matthews N., Stewart A., Tarpey P., Varela I., Phillimore B., Begum S., McDonald N.Q., Butler A., Jones D., Raine K., Latimer C., Santos C.R., Nohadani M., Eklund A.C., Spencer-Dene B., Clark G., Pickering L., Stamp G., Gore M., Szallasi Z., Downward J., Futreal P.A., Swanton C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N.Engl. J. Med. 2012, 366:883-892.
28. Ghazalpour A., Doss S., Zhang B., Wang S., Plaisier C., Castellanos R., Brozell A., Schadt E.E., Drake T.A., Lusis A.J., Horvath S. Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet. 2006, 2:e130.
29. Giritharan G., Ilic D., Gormley M., Krtolica A. Human embryonic stem cells derived from embryos at different stages of development share similar transcription profiles. PLoS One 2011, 6:e26570.
30. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., Lander E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
31. Gotea V., Ovcharenko I. DiRE: identifying distant regulatory elements of co-expressed genes. Nucleic Acids Res. 2008, 36:W133-W139.
32. Graham T.R., Zhau H.E., Odero-Marah V.A., Osunkoya A.O., Kimbro K.S., Tighiouart M., Liu T., Simons J.W., O'Regan R.M. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 2008, 68:2479-2488.
33. Hamilton J.P., Meltzer S.J. A review of the genomics of gastric cancer. Clin. Gastroenterol. Hepatol. 2006, 4:416-425.
34. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
35. Horvath S., Dong J. Geometric interpretation of genecoexpression network analysis. Plos Comput. Biol. 2008, 4:e1000117.
36. Hu Z., Snitkin E.S., DeLisi C. VisANT: an integrative framework for networks in systems biology. Brief Bioinform. 2008, 9:317-325.
37. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
38. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
39. Kitadai Y. Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer. Cancer Microenviron. 2010, 3:109-116.
40. Kuijjer M.L., Rydbeck H., Kresse S.H., Buddingh E.P., Lid A.B., Roelofs H., Burger H., Myklebost O., Hogendoorn P.C., Meza-Zepeda L.A., Cleton-Jansen A.M. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Genes Chromosomes Cancer 2012, 51:696-706.
41. Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559.
42. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 1965, 64:31-49.
43. Lei Z., Tan I.B., Das K., Deng N., Zouridis H., Pattison S., Chua C., Feng Z., Guan Y.K., Ooi C.H., Ivanova T., Zhang S., Lee M., Wu J., Ngo A., Manesh S., Tan E., Teh B.T., So J.B., Goh L.K., Boussioutas A., Lim T.K., Flotow H., Tan P., Rozen S.G. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology 2013, 145:554-565.
44. Levine D.M., Haynor D.R., Castle J.C., Stepaniants S.B., Pellegrini M., Mao M., Johnson J.M. Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol. 2006, 7:R93.
45. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U S A 2001, 98:31-36.
46. Liberzon A., Subramanian A., Pinchback R., Thorvaldsdottir H., Tamayo P., Mesirov J.P. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011, 27:1739-1740.
47. Milne A.N., Carneiro F., O'Morain C., Offerhaus G.J. Nature meets nurture: molecular genetics of gastric cancer. Hum. Genet. 2009, 126:615-628.
48. Mizuno H., Spike B.T., Wahl G.M., Levine A.J. Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc. Natl. Acad. Sci. U S A 2010, 107:22745-22750.
49. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J. Gastrointest. Oncol. 2012, 4:156-169.
50. Ogasawara N., Tsukamoto T., Mizoshita T., Inada K., Cao X., Takenaka Y., Joh T., Tatematsu M. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 2006, 49:612-621.
51. Ooi C.H., Ivanova T., Wu J., Lee M., Tan I.B., Tao J., Ward L., Koo J.H., Gopalakrishnan V., Zhu Y., Cheng L.L., Lee J., Rha S.Y., Chung H.C., Ganesan K., So J., Soo K.C., Lim D., Chan W.H., Wong W.K., Bowtell D., Yeoh K.G., Grabsch H., Boussioutas A., Tan P. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. Plos Genet. 2009, 5:e1000676.
52. Parsons S.J., Rhodes S.A., Connor H.E., Rees S., Brown J., Giles H. Use of a dual firefly and Renilla luciferase reporter gene assay to simultaneously determine drug selectivity at human corticotrophin releasing hormone 1 and 2 receptors. Anal. Biochemistry 2000, 281:187-192.
53. Periasamy J., Muthuswami M., Rao D.B., Tan P., Ganesan K. Stratification and delineation of gastric cancer signaling by invitro transcription factor activity profiling and integrative genomics. Cell Signalling 2014, 26:880-894.
54. Ponomarev I., Wang S., Zhang L., Harris R.A., Mayfield R.D. Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J.Neurosci. 2012, 32:1884-1897.
55. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., Rennert G., Moreno V., Kirchhoff T., Gold B., Assmann V., Elshamy W.M., Rual J.F., Levine D., Rozek L.S., Gelman R.S., Gunsalus K.C., Greenberg R.A., Sobhian B., Bertin N., Venkatesan K., Ayivi-Guedehoussou N., Sole X., Hernandez P., Lazaro C., Nathanson K.L., Weber B.L., Cusick M.E., Hill D.E., Offit K., Livingston D.M., Gruber S.B., Parvin J.D., Vidal M. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 2007, 39:1338-1349.
56. Qi H., Aguiar D.J., Williams S.M., La Pean A., Pan W., Verfaillie C.M. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc. Natl. Acad. Sci. U S A 2003, 100:3305-3310.
57. Qin S., Kim J., Arafat D., Gibson G. Effect of normalization on statistical and biological interpretation of gene expression profiles. Front Genet. 2012, 3:160.
58. Ron-Bigger S., Bar-Nur O., Isaac S., Bocker M., Lyko F., Eden A. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming. Stem Cells 2010, 28:1349-1354.
59. Saikawa Y., Fukuda K., Takahashi T., Nakamura R., Takeuchi H., Kitagawa Y. Gastric carcinogenesis and the cancer stem cell hypothesis. Gastric Cancer 2010, 13:11-24.
60. Schroeder M.P., Gonzalez-Perez A., Lopez-Bigas N. Visualizing multidimensional cancer genomics data. Genome Med. 2013, 5:9.
61. Sehn L.H. Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. Hematology Am. Soc. Hematol. Educ. Program 2012, 1:402-409.
62. Sell S. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol. 2004, 51:1-28.
63. Shah M.A., Khanin R., Tang L., Janjigian Y.Y., Klimstra D.S., Gerdes H., Kelsen D.P. Molecular classification of gastric cancer: a new paradigm. Clin. Cancer Res. 2011, 17:2693-2701.
64. Singh S.R. Gastric cancer stem cells: a novel therapeutic target. Cancer Lett. 2013, 338:110-119.
65. Spaeth E., Klopp A., Dembinski J., Andreeff M., Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008, 15:730-738.
66. Stains J.P., Civitelli R. Genomic approaches to identifying transcriptional regulators of osteoblast differentiation. Genome Biol. 2003, 4:222.
67. Stuart J.M., Segal E., Koller D., Kim S.K. A gene-coexpression network for global discovery of conserved genetic modules. Science 2003, 302:249-255.
68. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A 2005, 102:15545-15550.
69. Sung S.Y., Hsieh C.L., Wu D., Chung L.W., Johnstone P.A. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr. Probl. Cancer 2007, 31:36-100.
70. Tan I.B., Ivanova T., Lim K.H., Ong C.W., Deng N., Lee J., Tan S.H., Wu J., Lee M.H., Ooi C.H., Rha S.Y., Wong W.K., Boussioutas A., Yeoh K.G., So J., Yong W.P., Tsuburaya A., Grabsch H., Toh H.C., Rozen S., Cheong J.H., Noh S.H., Wan W.K., Ajani J.A., Lee J.S., Tellez M.S., Tan P. Intrinsic subtypes of gastric cancer, based on gene expressionpattern, predict survival and respond differently tochemotherapy. Gastroenterology 2011, 141:476-485. 485 e471-411.
71. Tay S.T., Leong S.H., Yu K., Aggarwal A., Tan S.Y., Lee C.H., Wong K., Visvanathan J., Lim D., Wong W.K., Soo K.C., Kon O.L., Tan P. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res. 2003, 63:3309-3316.
72. Teschendorff A.E., Gomez S., Arenas A., El-Ashry D., Schmidt M., Gehrmann M., Caldas C. Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. BMC Cancer 2010, 10:604.
73. The Cancer Genome Atlas Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
74. Tuxhorn J.A., Ayala G.E., Smith M.J., Smith V.C., Dang T.D., Rowley D.R. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin. Cancer Res. 2002, 8:2912-2923.
75. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2:333-344.
76. Wu Y., Grabsch H., Ivanova T., Tan I.B., Murray J., Ooi C.H., Wright A.I., West N.P., Hutchins G.G., Wu J., Lee M., Lee J., Koo J.H., Yeoh K.G., van Grieken N., Ylstra B., Rha S.Y., Ajani J.A., Cheong J.H., Noh S.H., Lim K.H., Boussioutas A., Lee J.S., Tan P. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut 2013, 62:1100-1111.
77. Yang L., Ping Y.F., Yu X., Qian F., Guo Z.J., Qian C., Cui Y.H., Bian X.W. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Lett. 2011, 310:46-52.
78. Yashiro M., Hirakawa K. Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron. 2010, 3:127-135.
79. Zang Z.J., Ong C.K., Cutcutache I., Yu W., Zhang S.L., Huang D., Ler L.D., Dykema K., Gan A., Tao J., Lim S., Liu Y., Futreal P.A., Grabsch H., Furge K.A., Goh L.K., Rozen S., Teh B.T., Tan P. Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing. Cancer Res. 2011, 71:29-39.
80. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005, 4. Article 17.
81. Zhang J., Xiang Y., Ding L., Keen-Circle K., Borlawsky T.B., Ozer H.G., Jin R., Payne P., Huang K. Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia. BMC Bioinformatics 2010, 11(Suppl. 9):S5.
82. Zhang Z., Zhou Y., Qian H., Shao G., Lu X., Chen Q., Sun X., Chen D., Yin R., Zhu H., Shao Q., Xu W. Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. Cell Death Dis. 2013, 4:e633.
83. Zhao M., Dumur C.I., Holt S.E., Beckman M.J., Elmore L.W. Multipotent adipose stromal cells and breast cancer development: think globally, act locally. Mol. Carcinog. 2010, 49:923-927.